Study obesity links to pancreatic cancer in specific groups
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how weight and related body changes may lead to pancreatic tumors, focusing on people who are African American or Non-Hispanic White. It may help researchers better understand why pancreatic cancer risk differs between groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 or older).
- You must self-identify as African American or Non-Hispanic White.
- You must be seen at a study site for suspected or diagnosed pancreatic tumor/cancer (GI clinic, surgery, or endoscopy).
- You must have a current concern or diagnosis of pancreatic cancer or tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how medical images and lab samples can predict which pancreatic cysts or tumors are more likely to be dangerous. If you are being evaluated for a pancreatic problem and haven’t started pancreas treatment, your scans and samples may help researchers improve risk prediction.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.